QIAGEN N.V. QGEN announced the launch of QIAcube Connect MDx platform for automated sample processing in molecular diagnostic laboratories. The platform will now be available in the United States and ...

VENLO, Netherlands, & GERMANTOWN, Maryland--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrument, a significant ...

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAcube Connect, which marks the next generation of QIAGEN’s ...

GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the global launch of the QIAcube Connect MDx, a flexible platform for ...

The QIAcube family is part of QIAGEN’s broader suite of automated nucleic acid extraction solutions, including QIAsymphony and EZ2 Connect, which together address the full spectrum of laboratory ...

Momentum building as QIAGEN prepares for three important new instrument launches in 2025 and 2026: QIAsymphony Connect, QIAsprint and QIAmini VENLO, Netherlands, & GERMANTOWN, Maryland--(BUSINESS WIRE ...